Browse Mass General News

Understanding the Role of Biological Sex in Age-Related Neurological Diseases

Researchers investigate the role of sex differences in age-related neurological diseases.

Research Spotlight: Simulation Model Shows Potential Affordability of Preventative HIV Therapy for Infants

Despite efforts to improve early maternal HIV diagnosis and increase accessibility of antiretroviral therapy to reduce the risk of transmission from 30% to less than 5%, about 130,000 children acquired HIV globally in 2023.

Researchers Identify Link to Kidney in Myotonic Dystrophy Type 1

Thurman M. Wheeler, MD, of the Department of Neurology at Massachusetts General Hospital, is the senior author of a paper published in Nature Communications, “Analysis of human urinary extracellular vesicles reveals disordered renal metabolism in myotonic dystrophy type 1.”

Healey & AMG Center for ALS Launches ALS MyMatch: an Early Phase Biomarker Driven Trial Program

Healey & AMG Center for ALS Launches ALS MyMatch: an Early Phase Biomarker Driven Trial Program

From the Bench- The Labs of Drs. Andrew Stern and Clare Baecher-Allen

From the Bench- The Labs of Drs. Andrew Stern and Clare Baecher-Allen. From the Bench- The Labs of Drs. Andrew Stern and Clare Baecher-Allen. We are excited to be expanding our network of ALS researchers and the impactful work being done across our

Research Spotlight: Projecting the Impact of Funding Cuts to the President’s Emergency Plan for AIDS Relief (PEPFAR)

Researchers found that eliminating PEPFAR would lead to 601,000 HIV-related deaths, 565,000 new HIV infections, and would increase population-level healthcare expenditure by $1.7 billion.

Research Spotlight: A Narrative Review of Medical Gaslighting

Researchers aimed to provide a starting point for future research into how gaslighting may present itself, what contributes to its occurrence and how to mitigate its impacts while considering the perspectives of both patients and providers.

Research Spotlight: New Imaging Method Could Improve Patient Selection for Cancer Immunotherapy

Researchers wanted to develop a new, more accurate method for measuring PD-L1 expression in tumors.

Research Spotlight: Innovative Nanovaccine Found to Trigger an Anti-Tumor Response for Rare Cancer

Researchers found that a nanovaccine can be used to treat a rare form of melanoma.

Research Spotlight: TB or Not TB? A New Clinician Decision Support Tool for Tuberculosis

Caitlin Dugdale, MD, MSc, and Kimon Zachary, MD, physicians in the Division of Infectious Diseases at Massachusetts General Hospital (MGH) and assistant professors of Medicine at Harvard Medical School, are co-lead authors of a new study in Infection Control and Hospital Epidemiology, TB or Not TB? Development and Validation of a Clinical Decision Support System for the Evaluation of Suspected Tuberculosis.